Bodal Chemicals Limited — Board Meeting, 12-08-2025: Outcome of Board Meeting
12-08-2025 | 02:52 pm
12-08-2025 | 02:52 pm
Bodal Chemicals' board meeting highlights: Q1 FY26 consolidated results show Revenue from Operations at Rs 454.20 Cr, with Net Profit at Rs 9.53 Cr and EPS of Rs 0.76. Key re-appointments include Mr. Mayank K Mehta as Independent Director (5 years), Mr. Suresh J. Patel as Chairman & MD (3 years), and Mr. Bhavin S. Patel as Executive Director (3 years), all subject to shareholder nod. New secretarial and statutory auditors were also appointed. A strategic move involves selling 7.86 acres of land at Unit-12 to a buyer who will utilize chlorine byproduct, aiming to ensure smooth operations and enhance earnings.
No comments yet. Be the first to comment!
